Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Depreciation and Depletion (2020 - 2025)

Historic Depreciation and Depletion for Mesa Laboratories (MLAB) over the last 6 years, with Q4 2025 value amounting to $1.3 million.

  • Mesa Laboratories' Depreciation and Depletion rose 1482.82% to $1.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $5.3 million, marking a year-over-year decrease of 35.43%. This contributed to the annual value of $5.4 million for FY2025, which is 2714.39% up from last year.
  • As of Q4 2025, Mesa Laboratories' Depreciation and Depletion stood at $1.3 million, which was up 1482.82% from $1.3 million recorded in Q3 2025.
  • Mesa Laboratories' 5-year Depreciation and Depletion high stood at $1.5 million for Q3 2024, and its period low was $911000.0 during Q3 2023.
  • For the 3-year period, Mesa Laboratories' Depreciation and Depletion averaged around $1.2 million, with its median value being $1.3 million (2025).
  • In the last 5 years, Mesa Laboratories' Depreciation and Depletion surged by 6663.01% in 2024 and then crashed by 1337.29% in 2025.
  • Quarter analysis of 3 years shows Mesa Laboratories' Depreciation and Depletion stood at $1.1 million in 2023, then increased by 2.98% to $1.1 million in 2024, then grew by 14.83% to $1.3 million in 2025.
  • Its Depreciation and Depletion stands at $1.3 million for Q4 2025, versus $1.3 million for Q3 2025 and $1.4 million for Q2 2025.